RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

RenovoRx announced today that the Company has filed an international patent application under the Patent Cooperation Treaty (PCT) for its novel Trans-Arterial Micro-Perfusion (TAMP) therapy platform.